Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

This study aimed to evaluate how the time to sputum culture conversion (SCC) predicts cure and to identify factors associated with delayed SCC and cure among multidrug-resistant tuberculosis (MDR-TB) patients receiving longer treatment regimens of 18-24 months. This multicenter retrospective cohort study was conducted at eight programmatic management units. A total of 462 patients with confirmed pulmonary MDR-TB were enrolled at eight PMDT sites between January 2017 and August 2018 with available treatment outcomes till 30th June, 2020. Survival analysis was done using the Kaplan-Meier curve, and Cox proportional hazards model and binary logistic regression were performed to determine factors associated with time to SCC and cure. Statistical significance was set at p<0.05. A total of 424/462 (91.8%) patients achieved SCC, with a cure rate of 75.5%. The mean time to SCC was 2.4 months (interquartile range = 1-3 months). Factors such as employment [hazard ratio (HR)=0.654, p=0.001], sputum smear grading score +2+3 (HR = 0.638, p=0.014), resistance to first-line drugs HREZ (HR=0.716, p=0.014), and resistance to second-line drugs, fluoroquinolones (HR=0.698, p≤0.001) were significantly associated with SCC. In the current study, the cure rate was 75.5% (349/462). In the binary logistic regression, month 1 [odds ratio (OR)=2.601, p≤0.001), month 2 (OR=3.14, p≤0.001), month 3 (OR=5.219, p≤0.001), month 4 (OR=6.788, p≤0.001), month 5 (OR=21.512, p≤0.001), and month 6 (OR=31.806, p≤0.001) had a statistically significant association with cure. In predicting cure, the overall sensitivities of SCC at 1, 2, 3, 4, 5, and 6 months were 37.2%, 64.1%, 85.9%, 91.1%, 97.4%, and 98.2%, respectively, and the specificities were 81.4%, 63.7%, 46.0%, 39.8%, 36.2%, and 35.3%, respectively. Interestingly, the combined sensitivity and specificity of SCC at 3 and 4 months in predicting cure were similar to those observed at 5 and 6 months.

Authors

Institutions

Publication Details

Journal
Monaldi Archives for Chest Disease
Published
2025-04-24
DOI
https://doi.org/10.4081/monaldi.2025.3200
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

Amjad Khan, Nafees Ahmad, Fahad Saleem, Faiz Ullah Khan et al.
Monaldi Archives for Chest Disease
Tuberculosis Research and Epidemiology
article

Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

Amjad Khan, Nafees Ahmad, Fahad Saleem, Faiz Ullah Khan, Asad Khan, Farman Ullah Khan, Abdul Wahid
article en

Abstract

This study aimed to evaluate how the time to sputum culture conversion (SCC) predicts cure and to identify factors associated with delayed SCC and cure among multidrug-resistant tuberculosis (MDR-TB) patients receiving longer treatment regimens of 18-24 months. This multicenter retrospective cohort study was conducted at eight programmatic management units. A total of 462 patients with confirmed pulmonary MDR-TB were enrolled at eight PMDT sites between January 2017 and August 2018 with available treatment outcomes till 30th June, 2020. Survival analysis was done using the Kaplan-Meier curve, and Cox proportional hazards model and binary logistic regression were performed to determine factors associated with time to SCC and cure. Statistical significance was set at p<0.05. A total of 424/462 (91.8%) patients achieved SCC, with a cure rate of 75.5%. The mean time to SCC was 2.4 months (interquartile range = 1-3 months). Factors such as employment [hazard ratio (HR)=0.654, p=0.001], sputum smear grading score +2+3 (HR = 0.638, p=0.014), resistance to first-line drugs HREZ (HR=0.716, p=0.014), and resistance to second-line drugs, fluoroquinolones (HR=0.698, p≤0.001) were significantly associated with SCC. In the current study, the cure rate was 75.5% (349/462). In the binary logistic regression, month 1 [odds ratio (OR)=2.601, p≤0.001), month 2 (OR=3.14, p≤0.001), month 3 (OR=5.219, p≤0.001), month 4 (OR=6.788, p≤0.001), month 5 (OR=21.512, p≤0.001), and month 6 (OR=31.806, p≤0.001) had a statistically significant association with cure. In predicting cure, the overall sensitivities of SCC at 1, 2, 3, 4, 5, and 6 months were 37.2%, 64.1%, 85.9%, 91.1%, 97.4%, and 98.2%, respectively, and the specificities were 81.4%, 63.7%, 46.0%, 39.8%, 36.2%, and 35.3%, respectively. Interestingly, the combined sensitivity and specificity of SCC at 3 and 4 months in predicting cure were similar to those observed at 5 and 6 months.

Monaldi Archives for Chest Disease
Quaid-i-Azam University (PK), University of Balochistan (PK), Capital University of Science and Technology (PK), CECOS University (PK)
Openalex Percentile: Top 89%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.